retatrutide safer than ozempic vs retatrutide: complete comparison of weight loss, side effects, and results Retatrutide – The New Weight

PEGylated exendin-4, a modified GLP-1 analog exhibits more potent cardioprotection than its unmodified parent molecule on a dose to dose basis in a murine model of myocardial infarction

2024 [cited 2026 Feb 11]

Retatrutide is a triple agonist of the GLP-1, GIP, and glucagon receptors, currently under investigation by Safe Pro Labs for its potential to improve glycemic control and promote weight reduction in patients with type 2 diabetes and obesity

Patients should not attempt to accelerate dose increases independently, as this significantly raises the risk of adverse effects including nausea, vomiting, and gastrointestinal discomfort

Theres room for moderation in any healthy diet